Navigation Links
Ian Tomlinson Joins SBC Board as GlaxoSmithKline Representative Director
Date:10/19/2011

nnovation & Skills, GlaxoSmithKline, the Wellcome Trust, the East of England Development Agency and the Technology Strategy Board. The £38m development will be an independent bioscience facility and is due to open in Q1 2012.

Photos available upon request

Notes to Editors

Ian Tomlinson - biography

Ian Tomlinson is SVP, Head of Biopharmaceuticals R&D and Worldwide Business Development (WWBD) and sits on GSK's R&D Executive Committee (RADEX). 

In his Biopharm R&D role Ian combines the resources and development expertise of a large pharmaceutical company, with the entrepreneurial spirit of a smaller biotech organization, bringing early research, late-stage biopharm development and manufacturing expertise into one organization.  This ambitious integrated strategy has taken GSK to a leading position in biopharmaceuticals, deriving over 20 percent of the pipeline from biopharmaceuticals.

In his business development role, Ian has global responsibility for all Pharmaceuticals R&D related business development activities for GSK. His team is committed to finding talent, ideas, and new medicines beyond the wall of GSK's internal Research & Development community.

Ian graduated from Trinity College, Cambridge, UK. He then spent 11 years at the MRC Laboratory of Molecular Biology in Cambridge, where he initially worked on the completion of the sequencing and mapping of all human antibody genes, and latterly on engineering recombinant antibodies. In 2000, together with Sir Gregory Winter, he co-founded Domantis Limited to develop an entirely new class of drugs based on the smallest fragments of antibodies, called Domain Antibodies, or "dAbs". Domantis was acquired by GSK in 2007.

About Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst is the UK's first open innovation bioscience campus, pioneering a unique culture to drive early stage drug discovery and development. It i
'/>"/>

SOURCE Stevenage Bioscience Catalyst
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
2. Amyris Chief Joins Renmatix BoD, New CFO Added to Company
3. Noted Author, Speaker, and Publisher, Gary Barg Joins BRAVE Awards Selection Committee
4. Eric Tornoe Joins Exagen Diagnostics as President and COO
5. Kelly Price Joins Los Angeles County Affiliate of Susan G. Komen for the Cure in the Fight Against Breast Cancer
6. Andrea Drucker Joins Insmed as General Counsel
7. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
8. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
9. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
10. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
11. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 The global ... billion in 2019. It is expected to grow ... 2019, and was valued at $1.8 billion in ... Transparency Market Research. , For more information regarding ... . , The research report, titled “Companion Diagnostics ...
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
(Date:8/29/2014)... 29, 2014 Pittcon is pleased to ... colleague Koichiro Matsuda, Horiba Scientific, have organized a session ... 2014. JASIS , Asia’s largest analytical and scientific ... Makuhari Messe, Japan. , The four speakers in ... from Single Molecules to Single Cells” will present their ...
(Date:8/29/2014)... 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or ... financial results for the six months ended June ... in Canadian dollars and presented under International Financial ... Highlights , Announced top-line results related ... endpoint for subjects enrolled in the Phase 2 ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4
... Colo., March 23 N30 Pharma (N30) today ... the Board of Directors of the Company.Dr. Loscalzo ... and Practice of Medicine at Harvard , ... Circulation, and has recently joined the senior editorial ...
... ("BVF") today announced that PROXY Governance, widely recognized as a ... for all BVF Proposals on the GOLD proxy card for ... ) to be held on March 27, 2009.In its report ... (BVF) must clear a high bar to justify a change ...
... March 23 PAREXEL International Corporation (Nasdaq: ... provider, today announced that the Company has received ... from BioSingapore, an industry association for life sciences ... Singapore. The award was presented to PAREXEL at ...
Cached Biology Technology:Leading Advisory Firm, PROXY Governance, Recommends Avigen Shareholders Vote on GOLD Card to Remove Incumbent Directors and Elect BVF's Stockholder-Oriented Nominees 2PAREXEL Receives BioSingapore Award for Best Performing CRO 2PAREXEL Receives BioSingapore Award for Best Performing CRO 3PAREXEL Receives BioSingapore Award for Best Performing CRO 4
(Date:8/29/2014)... U.S. Ebola researcher from the University of Texas Medical Branch ... of three monoclonal antibodies can completely protect monkeys against a ... infection, at a time when the disease is severe. , ... editorial for Nature discussing advances in Ebola treatment ... are among the most deadly of pathogens, with fatality rates ...
(Date:8/29/2014)... climatic shifts over the last 120,000 years may ... team of researchers led by City College of ... new biodiversity metric called "phylogeographic endemism." , It ... within species is restricted in geographical space. , ... 14 other researchers from institutions in Brazil, Australia ...
(Date:8/29/2014)... researchers explored the type and number of connections in ... plays on robustness in a study published in ... found that the assortativity signature contributes to a network,s ... that varying the out-out assortativity of TFN models has ... the other three types of assortativity," said Dov A. ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2CCNY team defines new biodiversity metric 2Assortativity signatures of transcription factor networks contribute to robustness 2
... at Vanderbilt University have "engineered" a mouse that can ... normal mouse by increasing its supply of acetylcholine, the ... month in the journal Neuroscience, could lead to new ... occurs when cholinergic nerve signals fail to reach the ...
... Plastics-based materials have been in use for decades. ... their quest for new developments: Substantial influences of ... cannot be observed directly. The synthetic polymer molecules ... mechanical experiments. A team of physicists led by ...
... scientists and physicians at the Medical College of Wisconsin and ... treat an unknown disease. For the one of the ... Medical College of Wisconsin and Children,s Hospital of Wisconsin sequenced ... previously-unknown mutation. The team was able not only to ...
Cached Biology News:Boosting supply of key brain chemical reduces fatigue in mice 2Muscle filaments make mechanical strain visible 2Scientists and physicians use genetic sequencing to identify and treat unknown disease 2
... of mouse embryonic stem cells to dopaminergic ... midbrain, where they are mainly located in ... and the retrorubral field. These dopaminergic (DA) ... innervation ( e.g.projections to the caudate nucleus, ...
... provides a comprehensive epitope analysis service ... on Paraflo microfluidic chips for immunological ... This comprehensive service includes assistance with ... sample(s) provided by you, single or ...
... ,Schistosomal glutathione-S-transferase (GST) is commonly used ... in E. coli (1). The GSTTag sequence ... and in some cases the solubility of ... soluble, properly folded form, GSTTag fusion proteins ...
... is commonly used as a fusion partner ... The GSTTag sequence has been reported to ... the solubility of its fusion partners. When ... GSTTag fusion proteins can be purified with ...
Biology Products: